Suppr超能文献

青蒿水提取物通过调节 ROS/MAPK 轴调控细胞凋亡来减轻阿霉素诱导的肾损伤。

Artemisia capillaris Thunb. water extract attenuates adriamycin-induced renal injury by regulating apoptosis through the ROS/MAPK axis.

机构信息

Division of Nephrology, Jiangsu Province Hospital of Traditional Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.

Key Laboratory for Metabolic Diseases in Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, China.

出版信息

J Food Biochem. 2022 Feb;46(2):e14065. doi: 10.1111/jfbc.14065. Epub 2022 Jan 5.

Abstract

Artemisia capillaris Thunb. is widely used in the treatment of kidney diseases, but the underlying mechanism remain elusive. Therefore, this study aimed to elucidate the mechanism of Artemisia capillaris Thunb. in alleviating renal injury. And renoprotective effects of freeze-dried powder of Artemisia capillaris Thunb. water extract (WAC) were assessed using adriamycin (ADR)-induced renal injury to the NRK-52E cells and ADR-induced renal injury Sprague-Dawley rats (SD rats) models. The results show that WAC could alleviate ADR-induced renal injury in SD rats and the NRK-52E cell line, improved renal function (BUN 9.73 ± 0.35 vs 7.13 ± 0.15, SCR 80.60 ± 1.68 vs 60.50 ± 1.42, ACR 11.50 ± 0.50 vs 8.526 ± 0.15) or cell viability (IC = 1.08 µg/ml (ADR), cell viability increase 36.38% ± 6.74% (added 4 mg/ml WAC)), and reduced the apoptosis. Moreover, WAC inhibited the MAPK signal transduction, increased the expression of superoxide dismutase 1 (SOD1), and decreased the production of ROS. The treatment of N-acetylcysteine (NAC, antioxidant) in vitro showed that NAC inhibited apoptosis and alleviated renal injury by inhibiting oxidative stress and reducing the phosphorylation of proteins related to the MAPK signaling pathway. Therefore, these results suggested that WAC can alleviate ADR-induced renal injury and apoptosis by regulating the ROS/MAPK axis and has potential to be used as a renoprotective drug. PRACTICAL APPLICATIONS: Artemisia capillaris Thunb., which is a medicinal and edible plant, is widely used to treat kidney diseases in traditional Chinese medicine. The present research examined the renal protective effect of Artemisia capillaris Thunb. The results show that Artemisia capillaris Thunb. can effectively reduce renal tubular cell apoptosis through the ROS/MAPK axis in vivo and in vitro. In general, Artemisia capillaris Thunb. can be used as a potential herb to attenuate renal injury and further research can be conducted to explore its renoprotective mechanisms.

摘要

黄花蒿(Artemisia capillaris Thunb.)广泛用于治疗肾脏疾病,但作用机制仍不清楚。因此,本研究旨在阐明黄花蒿提取物(WAC)减轻肾损伤的机制。采用阿霉素(ADR)诱导的 NRK-52E 细胞和 ADR 诱导的 Sprague-Dawley 大鼠(SD 大鼠)模型评估黄花蒿冻干粉(WAC)的肾保护作用。结果表明,WAC 可减轻 SD 大鼠和 NRK-52E 细胞系中 ADR 诱导的肾损伤,改善肾功能(BUN 9.73±0.35 比 7.13±0.15,SCR 80.60±1.68 比 60.50±1.42,ACR 11.50±0.50 比 8.526±0.15)或细胞活力(IC=1.08µg/ml(ADR),细胞活力增加 36.38%±6.74%(加入 4mg/ml WAC)),并减少细胞凋亡。此外,WAC 抑制 MAPK 信号转导,增加超氧化物歧化酶 1(SOD1)的表达,减少 ROS 的产生。体外给予 N-乙酰半胱氨酸(NAC,抗氧化剂)治疗表明,NAC 通过抑制氧化应激和减少与 MAPK 信号通路相关的蛋白磷酸化来抑制细胞凋亡和减轻肾损伤。因此,这些结果表明,WAC 通过调节 ROS/MAPK 轴可以减轻 ADR 诱导的肾损伤和细胞凋亡,并具有作为肾保护药物的潜力。实际应用:黄花蒿(Artemisia capillaris Thunb.)是一种药食同源植物,在中医中广泛用于治疗肾脏疾病。本研究考察了黄花蒿对肾脏的保护作用。结果表明,黄花蒿在体内和体外均可通过 ROS/MAPK 轴有效减少肾小管细胞凋亡。总的来说,黄花蒿可作为一种潜在的草药,减轻肾损伤,进一步的研究可以探索其肾保护机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验